Anika Therapeutics (ANIK) Research & Development (2016 - 2025)
Historic Research & Development for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $6.9 million.
- Anika Therapeutics' Research & Development rose 1681.8% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 6454.28%. This contributed to the annual value of $25.5 million for FY2024, which is 1737.35% up from last year.
- Per Anika Therapeutics' latest filing, its Research & Development stood at $6.9 million for Q3 2025, which was up 1681.8% from $6.3 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Research & Development registered a high of $8.9 million during Q2 2023, and its lowest value of -$3.3 million during Q4 2023.
- Over the past 5 years, Anika Therapeutics' median Research & Development value was $6.5 million (recorded in 2024), while the average stood at $5.9 million.
- Its Research & Development has fluctuated over the past 5 years, first tumbled by 13520.0% in 2022, then skyrocketed by 29470.38% in 2024.
- Anika Therapeutics' Research & Development (Quarter) stood at $6.0 million in 2021, then crashed by 135.2% to -$2.1 million in 2022, then crashed by 58.24% to -$3.3 million in 2023, then skyrocketed by 294.7% to $6.5 million in 2024, then grew by 6.75% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $6.3 million for Q2 2025, and $6.1 million during Q1 2025.